Diseases, Conditions, Syndromes

Rabies vaccine candidate begins human trials in Tanzania

The University of Oxford and the Ifakara Health Institute today announced the vaccination of the first participants in a Phase Ib/II trial testing a novel rabies vaccine in human volunteers in Tanzania.

Immunology

Researchers recommend investments in vaccine safety

The leaders of Mayo Clinic's Vaccine Research Group are emphasizing the need for increased long-term study of vaccines and their mechanisms with future safety of patients in mind.

Vaccination

Canada approves first domestic COVID-19 vaccine

Canadian health authorities approved Thursday the first domestic COVID-19 vaccine, Quebec City-based biopharmaceutical firm Medicago and its partner GlaxoSmithKline announced.

Diseases, Conditions, Syndromes

Pandemic's 'acute phase' could end by midyear: WHO

The head of the World Health Organization said Friday the acute phase of the pandemic could end this year, if around 70 percent of the world gets vaccinated.

page 17 from 40